These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21982294)

  • 1. Contact activation of blood plasma and factor XII by ion-exchange resins.
    Josh Yeh CH; Dimachkie ZO; Golas A; Cheng A; Parhi P; Vogler EA
    Biomaterials; 2012 Jan; 33(1):9-19. PubMed ID: 21982294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive-protein adsorption in contact activation of blood factor XII.
    Zhuo R; Siedlecki CA; Vogler EA
    Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoactivation of blood factor XII at hydrophilic and hydrophobic surfaces.
    Zhuo R; Siedlecki CA; Vogler EA
    Biomaterials; 2006 Aug; 27(24):4325-32. PubMed ID: 16644008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderation of prekallkrein-factor XII interactions in surface activation of coagulation by protein-adsorption competition.
    Chatterjee K; Thornton JL; Bauer JW; Vogler EA; Siedlecki CA
    Biomaterials; 2009 Oct; 30(28):4915-20. PubMed ID: 19552950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.
    Golas A; Pitakjakpipop H; Rahn MS; Siedlecki CA; Vogler EA
    Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of contact activation pathways of coagulation factor XII in plasma.
    Chatterjee K; Guo Z; Vogler EA; Siedlecki CA
    J Biomed Mater Res A; 2009 Jul; 90(1):27-34. PubMed ID: 18481791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact activation of blood-plasma coagulation.
    Vogler EA; Siedlecki CA
    Biomaterials; 2009 Apr; 30(10):1857-69. PubMed ID: 19168215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of blood factor XII autoactivation in buffer, protein cocktail, serum, and plasma solutions.
    Golas A; Yeh CH; Pitakjakpipop H; Siedlecki CA; Vogler EA
    Biomaterials; 2013 Jan; 34(3):607-20. PubMed ID: 23117212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.
    Mutch NJ; Waters EK; Morrissey JH
    J Thromb Haemost; 2012 Oct; 10(10):2108-15. PubMed ID: 22905925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amidolytic, procoagulant, and activation-suppressing proteins produced by contact activation of blood factor XII in buffer solution.
    Golas A; Yeh CH; Siedlecki CA; Vogler EA
    Biomaterials; 2011 Dec; 32(36):9747-57. PubMed ID: 21955686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nanobody-based method for tracking factor XII activation in plasma.
    de Maat S; van Dooremalen S; de Groot PG; Maas C
    Thromb Haemost; 2013 Sep; 110(3):458-68. PubMed ID: 23349032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface dependent contact activation of factor XII and blood plasma coagulation induced by mixed thiol surfaces.
    Bauer JW; Xu LC; Vogler EA; Siedlecki CA
    Biointerphases; 2017 May; 12(2):02D410. PubMed ID: 28514863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
    Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
    J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XII truncation accelerates activation in solution.
    de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
    J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical modeling of material-induced blood plasma coagulation.
    Guo Z; Bussard KM; Chatterjee K; Miller R; Vogler EA; Siedlecki CA
    Biomaterials; 2006 Feb; 27(5):796-806. PubMed ID: 16099033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
    Schousboe I; Nystrøm BT; Hansen GH
    FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XII in coagulation, inflammation and beyond.
    Didiasova M; Wujak L; Schaefer L; Wygrecka M
    Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
    Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
    Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
    Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo roles of factor XII.
    Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
    Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.